Back
 IJCM  Vol.11 No.5 , May 2020
Research Progress of C-Peptide and Its Physiological Function
Abstract: As a product in the process of insulin synthesis, C-peptide’s physiological function is still not very clear. Recent studies have shown that C-peptide has many potential cell targets and has biological effects on a variety of tissue systems in humans and other animals. In this paper, the effects of C-peptide on diabetic complications, reproductive endocrine system, blood system, tissue repair, and neoplastic diseases were reviewed to provide references for further clarification of c-peptide related problems.
Cite this paper: Zeng, R. , Huang, S. and Liao, S. (2020) Research Progress of C-Peptide and Its Physiological Function. International Journal of Clinical Medicine, 11, 207-215. doi: 10.4236/ijcm.2020.115021.
References

[1]   Ghorbani, A., Omrani, G., Hadjzadeh, M., et al. (2013) Proinsulin C-Peptide Inhibits Lipolysis in Diabetic Rat Adipose Tissue through Phosphodiestrase-3B Enzyme. Hormone & Metabolic Research, 45, 221-225.
https://doi.org/10.1055/s-0032-1323764

[2]   Xu, S., Jiang, Y., Wang, H., et al. (2015) C-Peptide Ameliorates Renal Injury in Type 2 Diabetic Rats through Protein Kinase A-Mediated Inhibition of Fibronectin Synthesis. Biochemical and Biophysical Research Communications, 458, 674-680.
https://doi.org/10.1016/j.bbrc.2015.02.022

[3]   Shaw, J.A., Shetty, P., Burns, K.D., et al. (2015) C-Peptide as a Therapy for Kidney Disease: A Systematic Review and Meta-Analysis. PLoS ONE, 10, e0127439.
https://doi.org/10.1371/journal.pone.0127439

[4]   Nakamoto, H., Nakayama, K., Emoto, N., et al. (2015) The Short-Term Effects of C-Peptide on the Early Diabetes-Related Ultrastructural Changes to the Podocyte Slit Diaphragm of Glomeruli in Rats. Microcirculation, 22, 122-132.
https://doi.org/10.1111/micc.12185

[5]   Boggi, U., Vistoli, F., Amorese, G., et al. (2011) Results of Pancreas Transplantation Alone with Special Attention to Native Kidney Function and Proteinuria in Type 1 Diabetes Patients. The Review of Diabetic Studies: RDS, 8, 259.
https://doi.org/10.1900/RDS.2011.8.259

[6]   Li, Y., Zhao, M., Li, B., et al. (2013) Dynamic Localization and Functional Implications of C-Peptide Might for Suppression of iNOS in High Glucose-Stimulated Rat Mesangial Cells. Molecular and Cellular Endocrinology, 381, 255-260.
https://doi.org/10.1016/j.mce.2013.08.007

[7]   Wang, J., Li, Y., Xu, M., et al. (2016) C-Peptide Exhibits a Late Induction Effect on Matrix Metallopeptidase-9 in High Glucose-Stimulated Rat Mesangial Cells. Experimental and Therapeutic Medicine, 12, 4142-4146.
https://doi.org/10.3892/etm.2016.3873

[8]   Luppi, P. and Drain, P. (2017) C-Peptide Antioxidant Adaptive Pathways in β Cells and Diabetes. Journal of Internal Medicine, 281, 7-24.
https://doi.org/10.1111/joim.12522

[9]   Chima, R.S., Maltese, G., LaMontagne, T., et al. (2011) C-Peptide Ameliorates Kidney Injury Following Hemorrhagic Shock. Shock (Augusta, Ga.), 35, 524.
https://doi.org/10.1097/SHK.0b013e31820b2e98

[10]   Yun, J.S., Lim, T.S., Cha, S.A., et al. (2016) Clinical Course and Risk Factors of Diabetic Retinopathy in Patients with Type 2 Diabetes Mellitus in Korea. Diabetes & Metabolism Journal, 40, 482-493.
https://doi.org/10.4093/dmj.2016.40.6.482

[11]   Chung, J.O., Cho, D.H., Chung, D.J., et al. (2015) Relationship between Serum C-Peptide Level and Diabetic Retinopathy According to Estimated Glomerular Filtration Rate in Patients with Type 2 Diabetes. Journal of Diabetes and Its Complications, 29, 350-355.
https://doi.org/10.1016/j.jdiacomp.2014.12.013

[12]   Kolar, G.R., Grote, S.M. and Yosten, G.L.C. (2017) Targeting Orphan G Protein-Coupled Receptors for the Treatment of Diabetes and Its Complications: C-Peptide and GPR 146. Journal of Internal Medicine, 281, 25-40.
https://doi.org/10.1111/joim.12528

[13]   Lim, Y.C., Bhatt, M.P., Kwon, M.H., et al. (2013) Prevention of VEGF-Mediated Microvascular Permeability by C-Peptide in Diabetic Mice. Cardiovascular Research, 101, 155-164.
https://doi.org/10.1093/cvr/cvt238

[14]   Wahren, J. and Larsson, C. (2015) C-Peptide: New Findings and Therapeutic Possibilities. Diabetes Research and Clinical Practice, 107, 309-319.
https://doi.org/10.1016/j.diabres.2015.01.016

[15]   Kuznetsova, A.V., Kurinov, A.M. and Aleksandrova, M.A. (2014) Cell Models to Study Regulation of Cell Transformation in Pathologies of Retinal Pigment Epithelium. Journal of Ophthalmology, 2014, Article ID: 801787.
https://doi.org/10.1155/2014/801787

[16]   Qiao, X., Zheng, H., Zhang, S., et al. (2017) C-Peptide Is Independent Associated with Diabetic Peripheral Neuropathy: A Community-Based Study. Diabetology & Metabolic Syndrome, 9, 12.
https://doi.org/10.1186/s13098-017-0208-2

[17]   Jolivalt, C.G., Rodriguez, M., Wahren, J., et al. (2015) Efficacy of a Long-Acting C-Peptide Analogue against Peripheral Neuropathy in Streptozotocin-Diabetic Mice. Diabetes, Obesity and Metabolism, 17, 781-788.
https://doi.org/10.1111/dom.12477

[18]   Wahren, J., Foyt, H., Daniels, M., et al. (2016) Long-Acting C-Peptide and Neuropathy in Type 1 Diabetes: A 12-Month Clinical Trial. Diabetes Care, 39, 596-602.
https://doi.org/10.2337/dc15-2068

[19]   Yosten, G.L.C., Maric-Bilkan, C., Luppi, P., et al. (2014) Physiological Effects and Therapeutic Potential of Proinsulin C-Peptide. American Journal of Physiology-Endocrinology and Metabolism, 307, E955-E968.
https://doi.org/10.1152/ajpendo.00130.2014

[20]   Pikkemaat, M., Andersson, T., Melander, O., et al. (2019) C-Peptide Predicts All-Cause and Cardiovascular Death in a Cohort of Individuals with Newly Diagnosed Type 2 Diabetes. The Skaraborg Diabetes Register. Diabetes Research and Clinical Practice, 150, 174-183.
https://doi.org/10.1016/j.diabres.2019.03.014

[21]   Wang, Y., Wan, H., Chen, Y., et al. (2019) Association of C-Peptide with Diabetic Vascular Complications in Type 2 Diabetes. Diabetes & Metabolism, 46, 33-40.
https://doi.org/10.1016/j.diabet.2019.04.004

[22]   Cardellini, M., Farcomeni, A., Ballanti, M., et al. (2017) C-Peptide: A Predictor of Cardiovascular Mortality in Subjects with Established Atherosclerotic Disease. Diabetes and Vascular Disease Research, 14, 395-399.
https://doi.org/10.1177/1479164117710446

[23]   Alves, M.T., Ortiz, M.M.O., dos Reis, G.V.O.P, et al. (2019) The Dual Effect of C-Peptide on Cellular Activation and Atherosclerosis: Protective or Not? Diabetes/Metabolism Research and Reviews, 35, e3071.
https://doi.org/10.1002/dmrr.3071

[24]   Li, Y., Zhao, D.D., Li, Y., et al. (2017) Serum C-Peptide as a Key Contributor to Lipid-Related Residual Cardiovascular Risk in the Elderly. Archives of Gerontology and Geriatrics, 73, 263-268.
https://doi.org/10.1016/j.archger.2017.05.018

[25]   Atsawarungruangkit, A., Chenbhanich, J. and Dickstein, G. (2018) C-Peptide as a Key Risk Factor for Non-Alcoholic Fatty Liver Disease in the United States Population. World Journal of Gastroenterology, 24, 3663.
https://doi.org/10.3748/wjg.v24.i32.3663

[26]   Mansour, A., Mohajeri-Tehrani, M.R., Samadi, M., et al. (2019) Risk Factors for Non-Alcoholic Fatty Liver Disease-Associated Hepatic Fibrosis in Type 2 Diabetes Patients. Acta Diabetologica, 56, 1199-1207.
https://doi.org/10.1007/s00592-019-01374-x

[27]   Garcia-Serrano, S., Gutiérrez-Repiso, C., Gonzalo, M., et al. (2015) C-Peptide Modifies Leptin and Visfatin Secretion in Human Adipose Tissue. Obesity, 23, 1607-1615.
https://doi.org/10.1002/oby.21137

[28]   Cernea, S., Roiban, A.L., Both, E., et al. (2018) Serum Leptin and Leptin Resistance Correlations with NAFLD in Patients with Type 2 Diabetes. Diabetes/Metabolism Research and Reviews, 34, e3050.
https://doi.org/10.1002/dmrr.3050

[29]   Montalcini, T., Gallotti, P., Coppola, A., et al. (2015) Association between Low C-Peptide and Low Lumbar Bone Mineral Density in Postmenopausal Women without Diabetes. Osteoporosis International, 26, 1639-1646.
https://doi.org/10.1007/s00198-015-3040-2

[30]   Pujia, A., Gazzaruso, C. and Montalcini, T. (2017) An Update on the Potential Role of C-Peptide in Diabetes and Osteoporosis. Endocrine, 58, 408-412.
https://doi.org/10.1007/s12020-017-1286-5

[31]   Nazmy, W.H., Elbassuoni, E.A., Ali, F.F., et al. (2019) Proinsulin C-Peptide as an Alternative or Combined Treatment with Insulin for Management of Testicular Dysfunction and Fertility Impairments in Streptozotocin-Induced Type 1 Diabetic Male Rats. Journal of Cellular Physiology, 234, 9351-9357.
https://doi.org/10.1002/jcp.27618

[32]   Aitken, R.J. and Koppers, A.J. (2011) Apoptosis and DNA Damage in Human Spermatozoa. Asian Journal of Andrology, 13, 36.
https://doi.org/10.1038/aja.2010.68

[33]   Wang, S., Zhang, M., Liang, B., et al. (2010) AMPKα2 Deletion Causes Aberrant Expression and Activation of NAD (P) H Oxidase and Consequent Endothelial Dysfunction in Vivo: Role of 26S Proteasomes. Circulation Research, 106, 1117.
https://doi.org/10.1161/CIRCRESAHA.109.212530

[34]   Chung, J.O., Park, S.Y., Cho, D.H., et al. (2018) Anemia Is Inversely Associated with Serum C-Peptide Concentrations in Individuals with Type 2 Diabetes. Medicine, 97, e11783.
https://doi.org/10.1097/MD.0000000000011783

[35]   Lim, Y.C., Bhatt, M.P., Kwon, M.H., et al. (2015) Proinsulin C-Peptide Prevents Impaired Wound Healing by Activating Angiogenesis in Diabetes. Journal of Investigative Dermatology, 135, 269-278.
https://doi.org/10.1038/jid.2014.285

[36]   Essid, S.M., Bevington, A. and Brunskill, N.J. (2019) Proinsulin C-Peptide Enhances Cell Survival and Protects against Simvastatin-Induced Myotoxicity in L6 Rat Myoblasts. International Journal of Molecular Sciences, 20, 1654.
https://doi.org/10.3390/ijms20071654

[37]   Tauber, Z., Cizkova, K., Janikova, M., et al. (2018) Serum C-Peptide Level Correlates with the Course of Muscle Tissue Healing in the Rabbit Model of Critical Limb Ischemia. Biomedical Papers of the Medical Faculty of the University Palacky, Olomouc, Czech Republic, 163, 132-140.

[38]   Hidaka, A., Budhathoki, S., Yamaji, T., et al. (2019) Plasma C-Peptide and Glycated Albumin and Subsequent Risk of Cancer: From a Large Prospective Case-Cohort Study in Japan. International Journal of Cancer, 144, 718-729.
https://doi.org/10.1002/ijc.31847

[39]   Stevens, V.L., Jacobs, E.J., Sun, J., et al. (2014) No Association of Plasma Levels of Adiponectin and c-Peptide with Risk of Aggressive Prostate Cancer in the Cancer Prevention Study II Nutrition Cohort. Cancer Epidemiology and Prevention Biomarkers, 23, 890-892.
https://doi.org/10.1158/1055-9965.EPI-14-0114

[40]   Jeon, H.Y., Lee, Y.J., Kim, Y.S., et al. (2018) Proinsulin C-Peptide Prevents Hyperglycemia-Induced Vascular Leakage and Metastasis of Melanoma Cells in the Lungs of Diabetic Mice. The FASEB Journal, 33, 750-762.
https://doi.org/10.1096/fj.201800723R

[41]   Nogueira, L.M., Newton, C.C., Pollak, M., et al. (2017) Serum C-Peptide, Total and High Molecular Weight Adiponectin, and Pancreatic Cancer: Do Associations Differ by Smoking? Cancer Epidemiology and Prevention Biomarkers, 26, 914-922.
https://doi.org/10.1158/1055-9965.EPI-16-0891

 
 
Top